Reaction Details |
| Report a problem with these data |
Target | HIV-1 protease |
---|
Ligand | BDBM468566 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Enzyme Inhibition of Purified HIV-1 Protease |
---|
IC50 | 12.2±n/a nM |
---|
Citation | Jude-Fishburn, CS; VanderVeen, LA; Riley, TA Protease inhibitors having enhanced features US Patent US10806794 Publication Date 10/20/2020 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
HIV-1 protease |
---|
Name: | HIV-1 protease |
Synonyms: | HIV-1 protease wild type |
Type: | Protein |
Mol. Mass.: | 10757.68 |
Organism: | Human immunodeficiency virus |
Description: | O90785 |
Residue: | 99 |
Sequence: | PQITLWQRPLVTVKIGGQLREALLDTGADDTVLEDINLPGKWKPKMIGGIGGFIKVKQYE
QVLIEICGKKAIGTVLVGPTPVNIIGRNMLTQIGCTLNF
|
|
|
BDBM468566 |
---|
n/a |
---|
Name | BDBM468566 |
Synonyms: | US10806794, Compound mPEG7-amide-Tipranavir |
Type | Small organic molecule |
Emp. Form. | C46H63F3N2O12S |
Mol. Mass. | 925.059 |
SMILES | CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(c2)N(CCOCCOCCOCCOCCOCCOCCOC)S(=O)(=O)c2ccc(cn2)C(F)(F)F)C(=O)O1 |t:15| |
Structure |
|